APA

Murphy Á. C., Weyhenmeyer B., Schmid J., Kilbride S. M., Rehm M., Huber H. J., Senft C., Weissenberger J., Seifert V., Dunst M., Mittelbronn M., Kögel D., Prehn J. H. M. & Murphy B. M. (20131023). Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach. : Cell death & disease.

Chicago

Murphy Á C, Weyhenmeyer B, Schmid J, Kilbride S M, Rehm M, Huber H J, Senft C, Weissenberger J, Seifert V, Dunst M, Mittelbronn M, Kögel D, Prehn J H M and Murphy B M. 20131023. Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach. : Cell death & disease.

Harvard

Murphy Á. C., Weyhenmeyer B., Schmid J., Kilbride S. M., Rehm M., Huber H. J., Senft C., Weissenberger J., Seifert V., Dunst M., Mittelbronn M., Kögel D., Prehn J. H. M. and Murphy B. M. (20131023). Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach. : Cell death & disease.

MLA

Murphy Á C, Weyhenmeyer B, Schmid J, Kilbride S M, Rehm M, Huber H J, Senft C, Weissenberger J, Seifert V, Dunst M, Mittelbronn M, Kögel D, Prehn J H M and Murphy B M. Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach. : Cell death & disease. 20131023.